Cases 41 - 50 of 91
Eisai Co. Ltd. et al. v. Mylan Pharmaceuticals Inc.
as 1:2013cv01282
Plaintiff:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co. Ltd. et al. v. Roxane Laboratories Inc.
as 1:2013cv01284
Plaintiff:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Defendant:
Roxane Laboratories Inc.
Counter_claimant:
Roxane Laboratories Inc.
Counter_defendant:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co. Ltd. et al. v. Glenmark Pharmaceuticals Ltd., et al.
as 1:2013cv01279
Plaintiff:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Defendant:
Glenmark Pharmaceuticals Ltd., Glenmark Generics Ltd. and Glenmark Generics Inc. USA
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co. Ltd. et al. v. Lupin Ltd., et al.
as 1:2013cv01281
Plaintiff:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eisai Co. Ltd. et al v. Hetero Labs Ltd., et al.
as 1:2013cv01280
Plaintiff:
Eisai Co. Ltd. , Eisai Inc. and Novartis Pharma AG
Defendant:
Hetero Labs Ltd. and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Noven Pharmaceuticals Inc.
as 1:2013cv00527
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Noven Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Actavis Inc. et al
as 1:2013cv00371
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Actavis Inc., Watson Pharmaceuticals Inc. , Watson Laboratories Inc. and others
Counter_claimant:
Watson Pharma Inc. , Watson Pharmaceuticals Inc. and Watson Laboratories Inc.
Counter_defendant:
LTS Lohmann Therapie-Systeme AG , Novartis AG , Novartis International Pharmaceutical Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Alvogen Pine Brook Inc. et al
as 1:2013cv00370
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Alvogen Pine Brook Inc. and Alvogen Group Inc.
Counter_claimant:
Alvogen Group Inc. and Alvogen Pine Brook Inc.
Counter_defendant:
LTS Lohmann Therapie-Systeme AG , Novartis AG , Novartis International Pharmaceutical Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Alvogen Pine Brook Inc. et al
as 1:2013cv00052
Plaintiff:
Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant:
Alvogen Pine Brook Inc. and Alvogen Group Inc.
Counter_claimant:
Alvogen Pine Brook Inc. and Alvogen Group Inc.
Counter_defendant:
LTS Lohmann Therapie-Systeme AG , Novartis AG , Novartis International Pharmaceutical Ltd. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
CELGENE CORPORATION et al v. MYLAN PHARAMACEUTICALS, INC.
as 2:2012cv07590
Plaintiff:
CELGENE CORPORATION , NOVARTIS PHARMACEUTICALS CORPORATION and NOVARTIS PHARMA AG
Defendant:
MYLAN PHARAMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
